Brief: Gentian Diagnostics Q1 EBITDA Rises To NOK 14.0 Million
07/05/2025 07:14
May 7 (Reuters) - Gentian Diagnostics ASA GENT.OL: Q1 SALES OF NOK 44.5 MILLION, UP 16% VERSUS 1Q24 Q1 EBITDA AT NOK 14.0 MILLION VERSUS NOK 4.8 MILLION IN 1Q24 Source text: ID:nObi925vha Further company coverage: GENT.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company